Citrate silver nanoparticles modulate estrogen signaling in estradiol-supplemented ER-positive breast cancer cells
Molecular and Cellular Endocrinology · 2026
DOI: 10.1016/j.mce.2026.112741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026. Verfasst von Michał Rakowski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Digital Biology and Biomedical Science - Biobank Łódź®, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.…. Hauptthemen laut MEDLINE: Silver, Signal Transduction, Breast Neoplasms, Metal Nanoparticles. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre Poland.
Abstract (Originalsprache)
BACKGROUND: Breast cancer remains the most common type of cancer affecting women. The estrogen receptor status of a tumor defines the therapeutic approach, which often includes endocrine treatment. Therefore, identifying potential endocrine-disrupting chemicals is of great importance. METHODS: In this study, we cultured MCF-7 cells supplemented with 17β-estradiol and treated them with silver and polystyrene nanoparticles. We measured the impact of nanoplastics on silver nanoparticle-induced modulation of basic cellular processes. Additionally, we assessed the significance of estrogen signaling in the observed changes induced by these nanomaterials and compared our observations with results obtained on estrogen-deprived MCF-7 cells and ER-negative SK-BR-3 cell line. RESULTS: We observed an induction of proliferation in cells treated with silver nanoparticles (AgNPs). In contrast, treatment with citrate silver nanoparticles (AgNPcit) at the same concentration induced cytotoxicity. Polystyrene nanoparticles (PSNPs) modulated the observed effects of silver nanoparticles in a size-dependent manner. Both AgNPs and AgNPcit downregulated the expression of GPER1. Treatment with nanomaterials also led to the modulation of genes linked to estrogen signaling, such as FOS, MYC, CAV1, and EGR3. CONCLUSIONS: Our results suggest that the surface chemistry of silver nanoparticles may facilitate their ability to modulate estrogen signaling and interact with the estrogen receptor. Furthermore, the nanoplastics pollution may influence the cytotoxicity of silver nanoparticles. This paper highlights the importance of endocrine research in breast cancer, particularly within the context of nanoplastics pollution and the use of nanotechnology in breast cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Digital Biology and Biomedical Science - Biobank Łódź®, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland. Electronic address: michal.rakowski@biol.uni.lodz.pl.
- Centre for Digital Biology and Biomedical Science - Biobank Łódź®, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland; The Bio-Med-Chem Doctoral School of the University of Lodz and Lodz I…
- Centre for Radiobiology and Biological Dosimetry, Institute of Nuclear Chemistry and Technology, Warsaw, Poland.
- Centre for Radiobiology and Biological Dosimetry, Institute of Nuclear Chemistry and Technology, Warsaw, Poland; Department of Molecular Biology and Translational Research, Institute of Rural Health, Lublin, Poland.
- Centre for Digital Biology and Biomedical Science - Biobank Łódź®, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
Förderung
- National Science Centre Poland
Zitieren
APA
Rakowski, M., Lekki-Porębski, S., Sikorska, K., Kruszewski, M., & Grzelak, A. (2026). Citrate silver nanoparticles modulate estrogen signaling in estradiol-supplemented ER-positive breast cancer cells. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2026.112741
Vancouver
Rakowski M, Lekki-Porębski S, Sikorska K, Kruszewski M, Grzelak A. Citrate silver nanoparticles modulate estrogen signaling in estradiol-supplemented ER-positive breast cancer cells. Molecular and Cellular Endocrinology. 2026. doi:10.1016/j.mce.2026.112741
BibTeX
@article{Rakowski2026,
author = {Rakowski, Michał and Lekki-Porębski, Szymon and Sikorska, Katarzyna and Kruszewski, Marcin and Grzelak, Agnieszka},
title = {Citrate silver nanoparticles modulate estrogen signaling in estradiol-supplemented ER-positive breast cancer cells},
journal = {Molecular and Cellular Endocrinology},
year = {2026},
doi = {10.1016/j.mce.2026.112741}
}
EUVIMED